Rockefeller Capital Management’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9K Sell
782
-309
-28% -$5.09K ﹤0.01% 3907
2026
Q1
$17.8K Buy
1,091
+485
+80% +$7.59K ﹤0.01% 3752
2025
Q4
$9K Sell
606
-4,336
-88% -$61.3K ﹤0.01% 3847
2025
Q3
$63.5K Buy
+4,942
New +$65.9K ﹤0.01% 2795
2023
Q1
Sell
-93
Closed -$1K 3572
2022
Q4
$1K Sell
93
-236
-72% -$3.05K ﹤0.01% 3750
2022
Q3
$3K Sell
329
-118
-26% -$1.68K ﹤0.01% 3509
2022
Q2
$5K Buy
447
+308
+222% +$3.95K ﹤0.01% 3474
2022
Q1
$1K Buy
139
+48
+53% +$634 ﹤0.01% 3774
2021
Q4
$1K Sell
91
-288
-76% -$4.92K ﹤0.01% 3688
2021
Q3
$6K Buy
+379
New +$7.52K ﹤0.01% 3122
2021
Q2
Sell
-431
Closed -$7K 3585
2021
Q1
$7K Hold
431
﹤0.01% 2778
2020
Q4
$6K Hold
431
﹤0.01% 2391
2020
Q3
$4K Hold
431
﹤0.01% 2300
2020
Q2
$3K Hold
431
﹤0.01% 2257
2020
Q1
$3K Buy
+431
New +$5.12K ﹤0.01% 2115

Other funds holding SEM

Rockefeller Capital Management's SEM Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Select Medical (SEM) stake by 28% in Q2 2026, selling an estimated $5.09K and leaving 782 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3907.

Rockefeller Capital Management first reported a position in SEM in Q1 2020 and has held it in 15 quarters since. The position peaked at $63.5K in Q3 2025. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Rockefeller Capital Management held 782 shares of Select Medical worth $12.9K as of Q2 2026.
  • Rockefeller Capital Management sold 309 Select Medical shares in Q2 2026, an estimated $5.09K.
  • Select Medical made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3907 holding.
  • Rockefeller Capital Management first reported a position in Select Medical in Q1 2020 and has held it in 15 quarters since.
  • Rockefeller Capital Management's Select Medical position peaked at $63.5K in Q3 2025.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.